CLEO Diagnostics Seeks ASX Quotation for Shares

CLEO Diagnostics Ltd (AU:COV) has released an update.

CLEO Diagnostics Ltd has announced the application for quotation of 7,500,000 of its ordinary fully paid shares on the ASX, with the security code COV. This application, dated June 24, 2024, follows the company’s adherence to the ASX Listing Rules and signifies a new opportunity for investors.

For further insights into AU:COV stock, check out TipRanks’ Stock Analysis page.